Highlights
NASDAQ: AMGN       Amgen Inc
Last Price Today's Change   Day's Range   Trading Volume
222.40   -4.03 (1.78%)  221.75 - 228.11  2,292,141

Overview

 
Avg Volume (4 weeks):2,929,836
4 Weeks Range:221.75 - 244.95
4 Weeks Price Volatility (%):
2.80%
52 Weeks Range:166.68 - 244.99
52 Weeks Price Volatility (%):
71.15%
Average Price Target: 140.00
Price Target Upside/Downside: -82.40

Headlines



No recent Headlines for this stock.


Business Background

Amgen Inc. is a biotechnology company. The Company discovers, develops, manufactures and delivers various human therapeutics. It operates in human therapeutics segment. Its marketed products portfolio includes Neulasta (pegfilgrastim); erythropoiesis-stimulating agents (ESAs), such as Aranesp (darbepoetin alfa) and EPOGEN (epoetin alfa); Sensipar/Mimpara (cinacalcet); XGEVA (denosumab); Prolia (denosumab); NEUPOGEN (filgrastim), and other marketed products, such as KYPROLIS (carfilzomib), Vectibix (panitumumab), Nplate (romiplostim), Repatha (evolocumab), BLINCYTO (blinatumomab), IMLYGIC (talimogene laherparepvec) and Corlanor (ivabradine). It focuses on human therapeutics for the treatment of serious illness in the areas of oncology/hematology, cardiovascular disease and neuroscience. Its product candidates in Phase III include Erenumab for episodic migraine, Aranesp for myelodysplastic syndromes, BLINCYTO for acute lymphoblastic leukemia and IMLYGIC for metastatic melanoma.

  Be the first to like this.
 


APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
 
 

2777  2995  197  2975 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 LK 2.13+0.74 
 SHIP 0.13-0.011 
 HTZ 0.555-2.285 
 GE 6.80+0.39 
 BAC 24.28+1.62 
 AAL 11.14+1.44 
 UAL 29.54+4.14 
 MARK 2.87+0.61 
 F 5.84+0.19 
 XSPA 0.933+0.053 
Partners & Brokers